Page last updated: 2024-10-30

metformin and Lead Poisoning

metformin has been researched along with Lead Poisoning in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Lead Poisoning: Poisoning that results from chronic or acute ingestion, injection, inhalation, or skin absorption of LEAD or lead compounds.

Research Excerpts

ExcerptRelevanceReference
"Metformin has both hypoglycaemic effects and reno-protection ability."1.48Metabolic profiling of metformin treatment for low-level Pb-induced nephrotoxicity in rat urine. ( Chen, SM; Huang, YS; Lee, JA; Wang, SH, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, YS1
Wang, SH1
Chen, SM1
Lee, JA1

Other Studies

1 other study available for metformin and Lead Poisoning

ArticleYear
Metabolic profiling of metformin treatment for low-level Pb-induced nephrotoxicity in rat urine.
    Scientific reports, 2018, 10-01, Volume: 8, Issue:1

    Topics: Administration, Oral; Animals; Biological Factors; Disease Models, Animal; Environmental Pollutants;

2018